Couto, J Pinto <br/><br/>
How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer.  [electronic resource] 

 -  Journal of clinical pathology  May 2009 
 - 414-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1472-4146 
<br/><br/><label>Standard No.: </label>10.1136/jcp.2008.055343  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma, Follicular--drug therapy<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Papillary--drug therapy<br/>DNA, Mitochondrial--genetics<br/>Gene Rearrangement<br/>Humans<br/>Mutation<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Proto-Oncogene Proteins c-ret--genetics<br/>Thyroid Neoplasms--drug therapy<br/>ras Proteins--genetics